Quantum BioPharma Ltd. (QNTM) is having a banner year in 2025, with its share price skyrocketing 730% year-to-date.
This biopharmaceutical company is focused on addressing critical unmet needs in treating challenging neurodegenerative and metabolic disorders and alcohol misuse disorders.
Formerly operating as FSD Pharma, Quantum BioPharma is the developer of unbuzzd, a scientifically formulated beverage designed to accelerate alcohol metabolism, thereby reducing both intoxication symptoms and hangover effects.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.